How much has Danaher stock declined in five years?

Danaher stock has declined about 18% over the past five years.

Is DHR stock undervalued currently?

According to Simply Wall St, the DCF model suggests the stock may trade at a discount to fair value, but earnings multiples imply a premium.

Danaher (DHR) Stock May Be Undervalued Despite 18% Five-Year Decline

According to Simply Wall St, Danaher (DHR) stock shows a valuation tension: DCF intrinsic value suggests meaningful upside, while earnings multiples imply a premium. The stock's 18% decline over five years frames the debate against weak long-term returns.

July 17, 2026

2 min read

Source: Simply Wall St.

Key Numbers

five year decline

18%

dcf upside

meaningful

According to Simply Wall St, Danaher (DHR) stock presents a clear valuation tension right now. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while earnings-based multiples suggest the shares are already pricing in a premium. Over the past five years, Danaher shareholders have seen the stock decline about 18%, framing the current valuation debate against a weaker long-term return profile.

Recommendation Change

No explicit recommendation change from a specific analyst is mentioned; rather, an independent valuation analysis suggests a potential buying opportunity based on DCF.

Analyst Rationale

The analysis uses a DCF model to calculate intrinsic value, which indicates the stock may trade below fair value. In contrast, earnings multiples (e.g., P/E) suggest a premium, creating a valuation discrepancy. Recent portfolio moves in diagnostics and pathology support positive expectations.

Context

No other analyst opinions are cited. The stock's five-year performance has been negative, with an 18% decline.

What We Conclude

The analysis offers a neutral view: DCF suggests a discount, while earnings multiples imply a premium. Investors should evaluate both perspectives before making decisions.

Frequently Asked Questions

The DCF model is a valuation method that estimates a stock's intrinsic value based on its expected future cash flows discounted to their present value.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.